Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDBioNexus Gene Lab Corp. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | $1.34 | $1.34 | $1.34 |
| Q2 2024 | 1 | $1.54 | $1.54 | $1.54 |
BioNexus Gene Lab Corp. Earnings Date And Information
BioNexus Gene Lab Corp. last posted its earnings results on N/A. The company reported $N/A earnings per share for the quarter, missing analysts' consensus estimates of $N/A by $0. The company had revenue of 2.63 M for the quarter and had revenue of 9.77 M for the year. BioNexus Gene Lab Corp. has generated $0 earnings per share over the last year ($-0.17 diluted earnings per share) and currently has a price-to-earnings ratio of -4.36. BioNexus Gene Lab Corp. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 18th, 2024 based on prior year's report dates.
BioNexus Gene Lab Corp. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/15/2024 | Q3 2024 | -$0.07 | $2.63 M | $2.63 M | ||
| 08/14/2024 | Q2 2024 | $0.01 | $1.97 M | $1.97 M | ||
| 05/15/2024 | Q1 2024 | -$0.01 | $2.38 M | |||
| 05/31/2024 | Q4 2023 | $0.02 | $2.27 M | |||
| 05/31/2024 | Q3 2023 | -$0.16 | $2.55 M | |||
| 05/31/2024 | Q2 2023 | -$0.02 | $2.57 M | |||
| 05/31/2024 | Q1 2023 | -$0.00 | $2.38 M | |||
| 05/31/2024 | Q4 2022 | -$0.01 | $2.84 M | |||
| 11/14/2022 | Q3 2022 | -$0.01 | $2.58 M | |||
| 08/15/2022 | Q2 2022 | -$0.01 | $2.49 M | |||
| 05/16/2022 | Q1 2022 | $0.00 | $3.03 M | |||
| 04/06/2022 | Q4 2021 | $0.01 | $3.25 M | |||
| 11/15/2021 | Q3 2021 | $0.02 | $3.58 M | |||
| 08/12/2021 | Q2 2021 | $0.00 | $3.09 M | |||
| 05/18/2021 | Q1 2021 | $0.02 | $3.45 M | |||
| 03/30/2021 | Q4 2020 | -$0.02 | $11.36 M | |||
| 11/03/2020 | Q3 2020 | $0.03 | $23,471 | |||
| 08/11/2020 | Q2 2020 | -$0.01 | $6,541 | |||
| 05/08/2020 | Q1 2020 | $0.12 | $3.07 M | |||
| 03/31/2020 | Q4 2019 | -$0.01 | $53,049 |
BioNexus Gene Lab Corp. Earnings: FAQ's
When is BioNexus Gene Lab Corp.'s earnings date?
BioNexus Gene Lab Corp. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 18th, 2024 based off last year's report dates.
How can I listen to BioNexus Gene Lab Corp.'s earnings conference
call?
The conference call for BioNexus Gene Lab Corp.'s latest earnings report can be listened to online.
How can I read BioNexus Gene Lab Corp.'s conference call transcript?
The conference call transcript for BioNexus Gene Lab Corp.'s latest earnings report can be read online.
How much revenue does BioNexus Gene Lab Corp. generate each year?
BioNexus Gene Lab Corp. (:BGLC) has a recorded annual revenue of $9.77 M.
How much profit does BioNexus Gene Lab Corp. generate each year?
BioNexus Gene Lab Corp. (:BGLC) has a recorded net income of $9.77 M. BioNexus Gene Lab Corp. has generated $-0.17 earnings per share over the last four quarters.
What is BioNexus Gene Lab Corp.'s price-to-earnings ratio?
BioNexus Gene Lab Corp. (:BGLC) has a price-to-earnings ratio of -4.36 and price/earnings-to-growth ratio is -0.07.